Oncotarget

Research Papers:

Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population

Bang-shun He, Tao Xu, Yu-qin Pan, Han-jin Wang, William C. Cho, Kang Lin, Hui-ling Sun, Tian-yi Gao and Shu-kui Wang _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:84872-84882. https://doi.org/10.18632/oncotarget.12744

Metrics: PDF 1244 views  |   HTML 1648 views  |   ?  


Abstract

Bang-shun He1, Tao Xu1, Yu-qin Pan1, Han-jin Wang2, William C. Cho3, Kang Lin1, Hui-ling Sun1, Tian-yi Gao4, Shu-kui Wang1

1General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

2Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

3Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China

4Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

Correspondence to:

Shu-kui Wang, email: shukwang@163.com

Keywords: association study, breast cancer, Chinese females, nucleotide excision repair (NER) pathway, polymorphism

Received: May 26, 2016     Accepted: October 10, 2016     Published: October 19, 2016

ABSTRACT

Polymorphisms in nucleotide excision repair (NER) pathway genes are associated with the risk of breast cancer, but the relevance of these associations appeared to vary according to the ethnicity of the subjects. To systemically evaluate the potential associations between NER polymorphisms and breast cancer risk in a Chinese population, we carried out a case-control study on 450 breast cancer patients and 430 healthy controls. Sequenom MassARRAY was used for genotyping, and immunohistochemistry was performed to detect estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression in tumor tissue. Our results showed that ERCC1 rs11615 (additive model: ORadjusted: 1.36, 95% CI: 1.08-1.71, p = 0.009), XPC rs2228000 (additive model: ORadjusted: 1.39, 95% CI: 1.13-1.72, p = 0.002) and ERCC2/XPD rs50872 (additive model: ORadjusted: 1.32, 95% CI: 1.04-1.67, p = 0.021) were associated with an increased risk of breast cancer. Stratified analysis revealed three polymorphisms (rs11615, rs1800975, and rs50872) to be associated with breast cancer in menopausal females. Three polymorphisms were associated with specific breast cancer grades (rs11615 with grade 3, rs2228000 and rs50872 with grade 1-2). Two polymorphisms (rs2228001 and rs50872) were associated with the risk of breast cancer with negative lymph node involvement. rs1800975 and rs50872 were associated with the risk of ER and PR breast cancer, whereas rs11615 was associated with the risk of ER+ and PR+ breast cancer. We found that carriers of the T allele of ERCC1 rs11615, XPC rs2228000 and rs50872, particularly in postmenopausal females, have an increased risk of breast cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 12744